APP Drug Hotline to assist healthcare professionals with shortage issues

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: APCVZ) announced today that it will launch the APP Drug Hotline on Wednesday, November 10, 2010. The APP Drug Hotline has been established to assist healthcare professionals with critical drug shortage issues.

“Management's Discussion and Analysis of Financial Condition and Results of Operations”

Staffed by an experienced Customer Service team, the APP Drug Hotline is dedicated to responding to inquires from healthcare professionals seeking information on whether APP's product portfolio can augment the supply of specific drugs currently on the U.S. Food and Drug Administration (FDA) and American Society of Health-System Pharmacists (ASHP) drug shortage lists. APP Drug Hotline staff will provide callers with an enhanced customer service experience, which includes real-time information on APP's available supply of specific drugs currently on drug shortage, details on upcoming APP product releases, as well as help callers track their APP orders.

"Throughout the years, APP Pharmaceuticals has demonstrated that it can meet the challenges of critical drug shortages, and we are acutely aware of the pressure that healthcare professionals are under when a needed drug is unavailable. We have worked collaboratively with the FDA to alleviate shortages for many products ranging from acyclovir to heparin and most recently propofol," said John Ducker, President and CEO, APP Pharmaceuticals. "Responsiveness is APP's commitment to healthcare professionals and we understand the importance of product supply meeting patient demand."

Healthcare professionals looking to learn more about how APP can help with their drug shortage needs can reach the APP Drug Hotline at (888) 386-1300, option 6. The APP Drug Hotline is available Monday through Friday, between the hours of 7:00 a.m. and 6:00 p.m. (CST).